Atlas Trials

Desipramine in Infantile Neuroaxonal Dystrophy (INAD).

Clinical trial NCT03726996 · TERMINATED

Trial details

NCT number
NCT03726996
Sponsor
Duke University
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Infantile Neuroaxonal Dystrophy
Start date
2019-01-14
Primary completion
2019-08-30
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.